73
Participants
Start Date
March 28, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
BNT142
Intravenous bolus/infusion
University of Pennsylvania, Philadelphia
University of Maryland Medical Center, Baltimore
NEXT Virginia, Fairfax
Duke University Medical Center, Durham
MD Anderson Cancer Center, Madrid
START Madrid-FJD Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario 12 de Octubre - Centro de Actividades Ambulatorias, Madrid
START Madrid CIOCC Hospital Universitario HM Sanchinarro, Madrid
Hospital Universitario Virgen de la Victoria Campus Universitario de Teatinos, Málaga
The University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START) - San Antonio, San Antonio
National University Cancer Institute - National University Hospital, Singapore
HM Nou Delfos General Hospital, Barcelona
Hospital Universitario Vall D'Hebron, Barcelona
Cambridge University Hospitals NHS Foundation Trust, Cambridge
The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
Hammersmith Hospital, Imperial College School Of Medicine - Imperial College Healthcare NHS Trust, London
Churchill Hospital - Oxford University Hospitals NHS Foundation Trust, Oxford
Lead Sponsor
BioNTech SE
INDUSTRY